Details
Product Name in the RMS: Levobupivacaïne Fresenius Kabi 1.25 mg/ml
MR Number: NL/H/2881/002
Date of outcome: 21.04.2014
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Additional Strength/Form Generic Chemical Substance Prescription Only |
Active Substances |
levobupivacaine hydrochloride 1,25 mg/ml |
Form | Solution for infusion |
MA Holder in the RMS |
Fresenius Kabi Deutschland GmbH Borkenberg 14 61440 Oberursel |
RMS | Netherlands |
Date of last change | 06.12.2019 |
ATC-Code |
N01BB10 Levobupivacaine |
CMS Country | Domestic Product Name |
---|---|
Belgium | Levobupivacaïne Fresenius Kabi 1,25mg/ml oplossing voor infusie |
France | |
Ireland | |
Italy | |
Slovenia | Levobupivakain Kabi 1,25 mg/ml raztopina za infundiranje |
Spain | |
United Kingdom |
Documents | |
---|---|
PAR: | NL_H_2881_002_PAR.pdf (30.10.2014) |
FinalSPC: | NL_H_2881_002_FinalSPC_1of5.pdf (15.10.2018) |
FinalSPC: | NL_H_2881_002_FinalSPC_2of5.pdf (15.10.2018) |
FinalSPC: | NL_H_2881_002_FinalSPC_3of5.pdf (15.10.2018) |
FinalSPC: | NL_H_2881_002_FinalSPC_4of5.pdf (15.10.2018) |
FinalSPC: | NL_H_2881_002_FinalSPC_5of5.pdf (15.10.2018) |
FinalPL: | NL_H_2881_002_FinalPL_1of3.pdf (15.10.2018) |
FinalPL: | NL_H_2881_002_FinalPL_2of3.pdf (15.10.2018) |
FinalPL: | NL_H_2881_002_FinalPL_3of3.pdf (15.10.2018) |
FinalLabelling: | NL_H_2881_002_FinalLabelling_1of2.pdf (15.10.2018) |
FinalLabelling: | NL_H_2881_002_FinalLabelling_2of2.pdf (15.10.2018) |